TozinameranInterstitial lung disease: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1886卷 / 1期

关键词：

D O I：

10.1007/s40278-021-07642-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：377 / 377

相关论文

共 50 条

[21] IxekizumabInterstitial lung disease: case report
Reactions Weekly, 2024, 2039 (1) : 285 - 285
[22] NivolumabInterstitial lung disease: case report
Reactions Weekly, 2018, 1712 (1) : 398 - 398
[23] GefitinibInterstitial lung disease: case report
Reactions Weekly, 2013, 1450 (1) : 18 - 18
[24] RituximabInterstitial lung disease: case report
Reactions Weekly, 2016, 1617 (1) : 196 - 196
[25] CrizotinibInterstitial lung disease: case report
Reactions Weekly, 2016, 1597 (1) : 70 - 70
[26] AntineoplasticsInterstitial lung disease: case report
Reactions Weekly, 2016, 1597 (1) : 24 - 24
[27] InfliximabInterstitial lung disease: case report
Reactions Weekly, 2015, 1551 (1) : 147 - 147
[28] GefitinibInterstitial lung disease: case report
Reactions Weekly, 2007, 1180 (1) : 18 - 18
[29] InfliximabInterstitial lung disease: case report
Reactions Weekly, 2022, 1931 (1) : 313 - 313
[30] ImatinibInterstitial lung disease: case report
Reactions Weekly, 2018, 1697 (1) : 187 - 187

← 1 2 3 4 5 →